FDA recall record

Precision Dose Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups recall — FDA D-0057-2018

Subpotent Drug: low out of specification results.

Class IIIclassification
D-0057-2018official record ID
Nov 8, 2017report date

Recall record at a glance

Official recordD-0057-2018
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmPrecision Dose Inc.
Report dateNov 8, 2017
Recall initiation dateSep 25, 2017
Quantity801 cases
LocationSouth Beloit, IL, United States

Official product description

Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59), packaged in 10-count cups per tray, 3 trays per case containing a total of 5 mL x 30 Unit Dose Cups per case (NDC 68094-301-62), Rx only, Pkg: Precision Dose, Inc., S. Beloit, IL 61080.

Why the product was recalled

Subpotent Drug: low out of specification results.

Distribution information

Nationwide in the USA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.